Inflammatory bowel disease (IBD) has a peak age of diagnosis before the age of 35 years.
Concerns about infertility, adverse pregnancy outcomes, and heritability of IBD have …

A growing number of patients with Crohn's disease and ulcerative colitis have disease that is
refractory to multiple advanced therapies, have undergone multiple surgeries and require …

2. Methods This document represents the third version of the European Consensus on
reproduction in IBD. The development of this Consensus included the formulation of …

Im Jahr 2019 wurden etwa 25 500 Patient* innen mit M. Crohn im Krankenhaus stationär
behandelt [1]. Meistens tritt die Erkrankung in der Adoleszenz und im jungen …

Anti-tumor necrosis factor (anti-TNF) therapy has been successfully used as first-line
biologic treatment for moderate-to-severe inflammatory bowel disease (IBD), in both “step …

Background Pregnancies in women with chronic disease are on the rise. This pertains to
autoimmune diseases in particular since these tend to affect women of childbearing age …

Background People with inflammatory or autoimmune diseases are recommended to
continue immunomodulatory biologic agents throughout pregnancy. However, concerns …

Background: Continuation of biologics for inflammatory disorders during pregnancy is still a
difficult decision. Many women with inflammatory bowel diseases (IBDs) stop anti–tumor …

Objective Active inflammatory bowel disease (IBD) during pregnancy may require the use of
corticosteroids. The aim of this study was to investigate the impact of in utero corticosteroid …

Abstract Background and Aims Evidence on the safety of newer biologics during pregnancy
is limited. We aimed to assess the safety of ustekinumab and vedolizumab treatment during …